Davita Healthcare Partners Stock Performance
| DVA Stock | USD 129.96 0.46 0.35% |
On a scale of 0 to 100, DaVita HealthCare holds a performance score of 14. The firm shows a Beta (market volatility) of 1.03, which means a somewhat significant risk relative to the market. DaVita HealthCare returns are very sensitive to returns on the market. As the market goes up or down, DaVita HealthCare is expected to follow. Please check DaVita HealthCare's skewness, day typical price, and the relationship between the downside variance and daily balance of power , to make a quick decision on whether DaVita HealthCare's price patterns will revert.
Risk-Adjusted Performance
14 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in DaVita HealthCare Partners are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating basic indicators, DaVita HealthCare sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (0.35) | Five Day Return (2.00) | Year To Date Return 21.58 | Ten Year Return 87.91 | All Time Return 3.1 K |
Last Split Factor 2:1 | Last Split Date 2013-09-09 |
1 | Disposition of 950 shares by John Nehra of DaVita HealthCare subject to Rule 16b-3 | 02/20/2024 |
2 | Philips , AWS Unite to Scale Digital Pathology Solutions | 03/13/2024 |
3 | Heres Why You Should Add Masimo to Your Portfolio Now | 03/19/2024 |
4 | Strykers Latest Launch to Streamline Procedural Workflows | 03/27/2024 |
5 | Acquisition by John Nehra of 366 shares of DaVita HealthCare subject to Rule 16b-3 | 03/28/2024 |
6 | Veeva Systems Makes Change to Front Office | 04/03/2024 |
7 | Glaukos iDose TR Receives Permanent J- Code From CMS | 04/04/2024 |
8 | AngioDynamics Q3 Earnings and Revenues Miss Estimates | 04/05/2024 |
9 | Why the Market Dipped But DaVita HealthCare Gained Today | 04/08/2024 |
10 | Thermo Fisher Launches TSX Universal Series ULT Freezers | 04/09/2024 |
11 | DaVita adds healthcare veteran Dennis Pullin to board | 04/10/2024 |
12 | DaVita HealthCare Stock Moves -0.75 percent What You Should Know | 04/12/2024 |
13 | Heres Why You Should Retain Glaukos Stock for Now | 04/15/2024 |
| Begin Period Cash Flow | 339 M |
DaVita |
DaVita HealthCare Relative Risk vs. Return Landscape
If you would invest 10,465 in DaVita HealthCare Partners on January 17, 2024 and sell it today you would earn a total of 2,531 from holding DaVita HealthCare Partners or generate 24.19% return on investment over 90 days. DaVita HealthCare Partners is generating 0.3678% of daily returns assuming volatility of 1.9324% on return distribution over 90 days investment horizon. In other words, 17% of stocks are less volatile than DaVita, and above 93% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
DaVita HealthCare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for DaVita HealthCare's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as DaVita HealthCare Partners, and traders can use it to determine the average amount a DaVita HealthCare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1904
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | DVA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.93 actual daily | 17 83% of assets are more volatile |
Expected Return
| 0.37 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.19 actual daily | 14 86% of assets perform better |
Based on monthly moving average DaVita HealthCare is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of DaVita HealthCare by adding it to a well-diversified portfolio.
DaVita HealthCare Fundamentals Growth
DaVita Stock prices reflect investors' perceptions of the future prospects and financial health of DaVita HealthCare, and DaVita HealthCare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on DaVita Stock performance.
| Return On Equity | 0.39 | ||||
| Return On Asset | 0.0592 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 23.85 B | ||||
| Shares Outstanding | 87.32 M | ||||
| Price To Earning | 11.43 X | ||||
| Price To Book | 10.78 X | ||||
| Price To Sales | 0.94 X | ||||
| Revenue | 12.14 B | ||||
| Gross Profit | 3.4 B | ||||
| EBITDA | 2.35 B | ||||
| Net Income | 691.53 M | ||||
| Cash And Equivalents | 244.09 M | ||||
| Cash Per Share | 3.98 X | ||||
| Total Debt | 11.12 B | ||||
| Debt To Equity | 5.68 % | ||||
| Current Ratio | 1.41 X | ||||
| Book Value Per Share | 11.89 X | ||||
| Cash Flow From Operations | 2.06 B | ||||
| Earnings Per Share | 7.42 X | ||||
| Market Capitalization | 11.39 B | ||||
| Total Asset | 17.62 B | ||||
| Retained Earnings | 598.29 M | ||||
| Working Capital | 495.69 M | ||||
| Current Asset | 544.53 M | ||||
| Current Liabilities | 292.6 M | ||||
About DaVita HealthCare Performance
To evaluate DaVita HealthCare Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when DaVita HealthCare generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare DaVita Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand DaVita HealthCare market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents DaVita's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 5.76 | 8.70 | |
| Return On Tangible Assets | 0.07 | 0.07 | |
| Return On Capital Employed | 0.11 | 0.15 | |
| Return On Assets | 0.04 | 0.04 | |
| Return On Equity | 0.65 | 0.69 |
Things to note about DaVita HealthCare performance evaluation
Checking the ongoing alerts about DaVita HealthCare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for DaVita HealthCare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| DaVita HealthCare has a strong financial position based on the latest SEC filings | |
| About 45.0% of the company shares are held by company insiders | |
| Latest headline from finance.yahoo.com: Heres Why You Should Retain Glaukos Stock for Now |
- Analyzing DaVita HealthCare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether DaVita HealthCare's stock is overvalued or undervalued compared to its peers.
- Examining DaVita HealthCare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating DaVita HealthCare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of DaVita HealthCare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of DaVita HealthCare's stock. These opinions can provide insight into DaVita HealthCare's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DaVita HealthCare Partners. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for DaVita Stock analysis
When running DaVita HealthCare's price analysis, check to measure DaVita HealthCare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DaVita HealthCare is operating at the current time. Most of DaVita HealthCare's value examination focuses on studying past and present price action to predict the probability of DaVita HealthCare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DaVita HealthCare's price. Additionally, you may evaluate how the addition of DaVita HealthCare to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |
Is DaVita HealthCare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DaVita HealthCare. If investors know DaVita will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DaVita HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.2 | Earnings Share 7.42 | Revenue Per Share 133.717 | Quarterly Revenue Growth 0.078 | Return On Assets 0.0592 |
The market value of DaVita HealthCare is measured differently than its book value, which is the value of DaVita that is recorded on the company's balance sheet. Investors also form their own opinion of DaVita HealthCare's value that differs from its market value or its book value, called intrinsic value, which is DaVita HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DaVita HealthCare's market value can be influenced by many factors that don't directly affect DaVita HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DaVita HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if DaVita HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DaVita HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.